Neuphoria Therapeutics, Inc. is a clinical-stage biotechnology company dedicated to developing therapies that address the complex needs of individuals affected by neuropsychiatric disorders. It focuses on developing BNC210, an oral drug designed for the acute treatment of social anxiety disorder (SAD) and the chronic treatment of post-traumatic stress disorder (PTSD) by selectively targeting the a7 nicotinic acetylcholine receptor. The company was founded in 1996 and is headquartered in Millis, MA.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
1
Frequently Asked Questions
Market cap, also known as market capitalization, is the total market value of a company. It's calculated by multiplying the current market price by the total number of shares outstanding. Neuphoria Therapeutics Inc. market cap is $12.28M.
52 week high is the highest price of a stock in the past 52 weeks, or one year. Neuphoria Therapeutics Inc. 52 week high is $5.53 as of November 18, 2026.
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Neuphoria Therapeutics Inc. 52 week low is $2.26 as of November 18, 2026.
Neuphoria Therapeutics Inc. stock price today is $2.28.
Neuphoria Therapeutics Inc. stock price yesterday was $2.27.
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It's calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company's Market Cap by the Net Profit. Neuphoria Therapeutics Inc.'s P/E ratio is -0.37.
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It's calculated by dividing a company's market capitalization by its book value. Neuphoria Therapeutics Inc. P/B ratio is 0.4993.
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It's calculated by averaging the closing stock price over the previous 50 trading days. Neuphoria Therapeutics Inc. 50-day moving average is $3.31.